Document is current
Any future updates will be listed below
-
Authors
Kamla, Christine-Elena
Meersch-Dini, Melanie
Palma, Lilian Monteiro Pereira
-
Funding
Funding for this research was provided by:
Alexion Pharmaceuticals
Klinikum der Universität München
- License Information
-
More Information
Article History
Accepted: 15 December 2024
First Online: 12 January 2025
Declarations
:
: Dr Kamla is the site investigator for the ARTEMIS trial at the University Hospital LMU Munich. Dr Meersch-Dini has received lecture fees from Fresenius Medical Care and Baxter and an unrestricted research grant from Baxter. Dr Palma has received honoraria from Alexion, AstraZeneca Rare Disease Brazil, and consultancy fees from Novartis and Apellis.
: All authors contributed to writing and reviewing the article. All authors have read and approved the final version of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: This is a review article, with no new experimental data generated in either humans or animal models. Therefore, no ethical approval was required.
